{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1361137044338423552.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1016/j.bmc.2013.12.041"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0968089613010493?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0968089613010493?httpAccept=text/plain"}}],"dc:title":[{"@value":"Targeting the Warburg Effect in cancer; relationships for 2-arylpyridazinones as inhibitors of the key glycolytic enzyme 6-phosphofructo-2-kinase/2,6-bisphosphatase 3 (PFKFB3)"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1381137044338423552","@type":"Researcher","foaf:name":[{"@value":"Darby G. Brooke"}]},{"@id":"https://cir.nii.ac.jp/crid/1381137044338423553","@type":"Researcher","foaf:name":[{"@value":"Ellen M. van Dam"}]},{"@id":"https://cir.nii.ac.jp/crid/1381137044338423556","@type":"Researcher","foaf:name":[{"@value":"Colin K.W. Watts"}]},{"@id":"https://cir.nii.ac.jp/crid/1381137044338423559","@type":"Researcher","foaf:name":[{"@value":"Amanda Khoury"}]},{"@id":"https://cir.nii.ac.jp/crid/1381137044338423554","@type":"Researcher","foaf:name":[{"@value":"Marie A. Dziadek"}]},{"@id":"https://cir.nii.ac.jp/crid/1381137044338423560","@type":"Researcher","foaf:name":[{"@value":"Hilary Brooks"}]},{"@id":"https://cir.nii.ac.jp/crid/1381137044338423558","@type":"Researcher","foaf:name":[{"@value":"Lisa-Jane K. Graham"}]},{"@id":"https://cir.nii.ac.jp/crid/1381137044338423555","@type":"Researcher","foaf:name":[{"@value":"Jack U. Flanagan"}]},{"@id":"https://cir.nii.ac.jp/crid/1381137044338423557","@type":"Researcher","foaf:name":[{"@value":"William A. Denny"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"09680896"}],"prism:publicationName":[{"@value":"Bioorganic & Medicinal Chemistry"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"2014-02","prism:volume":"22","prism:number":"3","prism:startingPage":"1029","prism:endingPage":"1039"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/","https://www.elsevier.com/legal/tdmrep-license"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S0968089613010493?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S0968089613010493?httpAccept=text/plain"}],"createdAt":"2014-01-03","modifiedAt":"2025-10-19","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360848657337519360","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"A strategy for improving FDG accumulation for early detection of metastasis from primary pancreatic cancer: Stimulation of the Warburg effect in AsPC-1 cells"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1016/j.bmc.2013.12.041"},{"@type":"CROSSREF","@value":"10.1016/j.nucmedbio.2014.12.017_references_DOI_98mX0MsF5r3PVRJJ5EdcOziwnz9"}]}